Journal
BIOCHEMICAL PHARMACOLOGY
Volume 68, Issue 3, Pages 417-421Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2004.03.038
Keywords
6-(p-bromophenyl)amino-7-(p-chlorophenyl)indazolo[2 ',3 ': 1,5]-1,2,4-triazolo[4,3-a]-1,3,5-benzotriazepine; cyclo-oxygenase-2; heme oxygenase-1; matrix metalloproteinase-13; osteoarthritis; interleukin-10
Categories
Ask authors/readers for more resources
ITB (6-(p-bromophenyl)amino-7-(p-chlorophenyl)indazolo[2',3':1,5]-1,2,4-triazolo[4,3-a]-1,3,5-benzotriazepine) is a novel inhibitor of cyclo-oxygenase-2 (COX-2) with anti inflammatory activity in animal models. In the present study, we investigated the effect of this compound on the production of catabolic or anti inflammatory mediators in osteoarthritis (OA) cartilage. In OA cartilage explants, ITB inhibited the production of prostaglandin E-2 (PGE(2)), tumour necrosis factor-alpha (TNF-alpha) and matrix metalloproteinase-13 (MMP-13) in a concentration-dependent manner, whereas nitrite was partially reduced. On the contrary, ITB increased the production of interleukin (IL)-10 and the expression of heme oxygenase-1 (HO-4). ITB inhibited the production of catabolic mediators at concentrations able to increase IL-10 and HO-1 in OA cartilage, suggesting that this compound may be useful in the prevention of cartilage degradation. (C) 2004 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available